The synthetic peptide SVVYGLR promotes cell motility of myogenic cells and facilitates differentiation in skeletal muscle regeneration.

The present study was designed to evaluate the effects of the osteopontin-derived multifunctional short peptide, SVVYGLR (SV) peptide on the biological properties of skeletal muscle-specific myogenic cells. We employed human-derived satellite cells (HSkMSC) and skeletal muscle myoblasts (HSMM) and performed a series of biochemical experiments. The synthetic SV peptide showed no influence on the proliferation and adhesion properties of HSkMSC and HSMM, while it showed a significant increase in cell motility, including migration activities upon treatment with the SV peptide. In a rat model with volumetric loss of masticatory muscle, immunohistochemical staining of regenerating muscle tissue immediately after injury demonstrated an increase of the number of both MyoD- and myogenin-positive cells in SV peptide-treated group. These results suggest that SV peptide plays a potent role in facilitating skeletal muscle regeneration by promoting the migration, and differentiation of myogenic precursor and progenitor cells.

[1]  H. Yatani,et al.  Synthetic osteopontin-derived peptide SVVYGLR can induce neovascularization in artificial bone marrow scaffold biomaterials. , 2007, Dental materials journal.

[2]  R. Farrar,et al.  Controlled delivery of SDF-1α and IGF-1: CXCR4(+) cell recruitment and functional skeletal muscle recovery. , 2015, Biomaterials science.

[3]  M. Hemler,et al.  Role of Transmembrane 4 Superfamily (Tm4sf) Proteins Cd9 and Cd81 in Muscle Cell Fusion and Myotube Maintenance , 1999, The Journal of cell biology.

[4]  U. Müller,et al.  Beta1 integrins regulate myoblast fusion and sarcomere assembly. , 2003, Developmental cell.

[5]  C. Rathbone,et al.  Volumetric muscle loss leads to permanent disability following extremity trauma. , 2015, Journal of rehabilitation research and development.

[6]  G. Vanderstraeten,et al.  Treatment of Skeletal Muscle Injury: A Review , 2012, ISRN orthopedics.

[7]  M. Kogo,et al.  Osteopontin-derived synthetic peptide SVVYGLR has potent utility in the functional regeneration of oral and maxillofacial skeletal muscles , 2019, Peptides.

[8]  B. Carlson,et al.  MyoD and myogenin protein expression in skeletal muscles of senile rats , 2003, Cell and Tissue Research.

[9]  Y. Tsao,et al.  PEDF-derived peptide promotes skeletal muscle regeneration through its mitogenic effect on muscle progenitor cells. , 2015, American journal of physiology. Cell physiology.

[10]  M. Sampaolesi,et al.  Cell therapy strategies and improvements for muscular dystrophy , 2010, Cell Death and Differentiation.

[11]  K. Uaesoontrachoon,et al.  Osteopontin and skeletal muscle myoblasts: association with muscle regeneration and regulation of myoblast function in vitro. , 2008, The international journal of biochemistry & cell biology.

[12]  A. Uchinaka,et al.  Evaluation of dermal wound healing activity of synthetic peptide SVVYGLR. , 2017, Biochemical and biophysical research communications.

[13]  A. Uchinaka,et al.  Improvement of cardiac function after implanting the osteopontin-derived peptide SVVYGLR in a hamster model of dilated cardiomyopathy. , 2015, Interactive cardiovascular and thoracic surgery.

[14]  Jeff W Lichtman,et al.  Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors , 2009, Proceedings of the National Academy of Sciences.

[15]  C. Pagel,et al.  Osteopontin, inflammation and myogenesis: influencing regeneration, fibrosis and size of skeletal muscle , 2013, Journal of Cell Communication and Signaling.

[16]  N. Adachi,et al.  Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model , 2009, Journal of cellular and molecular medicine.

[17]  K. Myburgh,et al.  In vitro myoblast motility models: investigating migration dynamics for the study of skeletal muscle repair , 2013, Journal of Muscle Research and Cell Motility.

[18]  A. Uchinaka,et al.  Overexpression of collagen type III in injured myocardium prevents cardiac systolic dysfunction by changing the balance of collagen distribution , 2018, The Journal of thoracic and cardiovascular surgery.

[19]  M. Sandri,et al.  Mechanisms regulating skeletal muscle growth and atrophy , 2013, The FEBS journal.

[20]  P. Lønning,et al.  Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. , 2009, Cancer research.

[21]  D. Sassoon,et al.  Stem cells in the hood: the skeletal muscle niche. , 2012, Trends in molecular medicine.

[22]  A. Uchinaka,et al.  Transplantation of myoblast sheets that secrete the novel peptide SVVYGLR improves cardiac function in failing hearts. , 2013, Cardiovascular research.

[23]  M. Matsuo,et al.  Angiogenic activity of osteopontin-derived peptide SVVYGLR. , 2003, Biochemical and biophysical research communications.

[24]  M. Rudnicki,et al.  Determination versus differentiation and the MyoD family of transcription factors. , 1995, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[25]  C. Sen,et al.  miRNA control of tissue repair and regeneration. , 2015, The American journal of pathology.

[26]  Adeline Koh,et al.  Osteopontin Expression Is Required for Myofibroblast Differentiation , 2008, Circulation research.

[27]  W. Benedict,et al.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.

[28]  A. Uchinaka,et al.  SVVYGLR motif of the thrombin-cleaved N-terminal osteopontin fragment enhances the synthesis of collagen type III in myocardial fibrosis , 2015, Molecular and Cellular Biochemistry.

[29]  J. Chen,et al.  Differential effects of the integrins alpha9beta1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin. Roles of the beta subunit extracellular and cytoplasmic domains. , 1996, The Journal of biological chemistry.

[30]  A. Schilling,et al.  Current Methods for Skeletal Muscle Tissue Repair and Regeneration , 2018, BioMed research international.